Cambridge Heart, Inc. Announces Initial Results of OEM Module Marketing Promotion
Published: Oct 20, 2011
TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that the marketing promotion it launched with its OEM partner, Cardiac Science, in July 2011 has yielded an initial increase in placements of its Microvolt T-Wave Alternans™ (MTWA) OEM Module. Since the implementation of the promotion in late July through the quarter ended September 30th 2011, 45 OEM Modules were shipped to purchasers of Cardiac Science’s Q-Stress system, compared with 13 units shipped in the preceding nine months.